Yahoo Finance

Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/diabetic-foot-ulcer-dfu-treatment-market-101948

Drivers & Restraints
Increasing Adoption of Extracellular Matrix Proteins to Propel Growth

A rise in the geriatric population and their vulnerability to various chronic diseases stand as the key drivers for promoting the diabetic foot ulcer treatment market growth. This, coupled with the increasing adoption of novel wound care devices, is aiding in the expansion of the market. Additionally, a rise in the availability of treatment option for diabetic foot ulcer is likely to augment the market growth in the coming years.

On the contrary, factors such as high cost of the advanced wound care therapies and devices and the lack of reimbursement policies may cause hindrance to the market growth in the coming years. Despite this, the advent and the increasing popularity of extracellular matrix proteins, bioengineered skin substitutes, and others are likely to create lucrative growth opportunities for the market for DFU treatment in the coming years.

Quick Buy Diabetic Foot Ulcer Treatment
https://www.fortunebusinessinsights.com/checkout-page/101948

COVID-19 Impact on Market:

On account of the current COVID-19 pandemic, most of the non-emergency procedures in the healthcare sector have been put on the delay. A report by the general surgeons at the American College of Surgeons and the U.S. Centers for Medicare and Medicaid Services (CMS) states that all non-essential surgical and medical services will be cancelled as a necessary precaution against the spread of the virus. Most of the healthcare resources in the other nations are following similar procedures. This is likely to pose a significant threat to this market in the coming years.

Get your Customized Research Report:

https://www.fortunebusinessinsights.com/enquiry/customization/diabetic-foot-ulcer-dfu-treatment-market-101948

Segment:

Wound Care Dressings Segment Bagged Major Share Owing to Cost-efficiency

Based on segmentation by product, the wound care dressings segment earned 42.7% diabetic foot ulcer treatment market share in 2019 and emerged dominant. This is owing to the cost-efficiency of these treatment procedures, less time taken to heal the wounds, and the overall exudate management.

Major Share Held by North America Owing to Increasing Prevalence of Diabetic Foot ulcer

Geographically, North America emerged dominant in the market for diabetic foot ulcer treatment, with a revenue of USD 2.79 billion generated in 2019. This is accountable to the presence of a well-established healthcare sector, increasing prevalence of the disease, and the growing launch of advanced solutions for wound care in the region.

Asia Pacific is expected to rise at a rapid pace in the forecast duration owing to the improving medical infrastructure and development, a rise in the diabetic population, and the increasing cases of foot ulcer among them.

Competitive Landscape

Coloplast Corp., ConvaTec Group Plc., and Smith & Nephew Earned Major Share Owing to Robust Research Activities

This global market earns major share from companies such as Mölnlycke Health Care AB, Smith & Nephew, Coloplast Corp, and ConvaTec Group Plc. Factors responsible for their dominance are the availability of a wide range of products and the significant investments in research and development activities in innovative product development. Furthermore, the strategic partnerships such as contracts and agreements, joint ventures, and others would help the companies in gaining traction in the global market.

Diabetic Foot Ulcer Treatment Market Segmentations:

Some of the Key Players of the DFU Treatment Market Include:

• 3M (Minnesota, United States)

• B. Braun Melsungen AG (Melsungen, Germany)

• Smith & Nephew (London, U.K.)

• Tissue Regenix (West Yorkshire, U.S.)

• ConvaTec Group Plc(England, U.K.)

• Cardinal Health (Ohio, United States)

• Coloplast Corp (Humlebaek, Denmark)

• Integra LifeSciences Corporation (New Jersey, United States)

• Mölnlycke Health Care AB (Gothenburg, Sweden)

• Other players

Have Any Query? Ask Our Experts

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/diabetic-foot-ulcer-dfu-treatment-market-101948

Table of Content

• Introduction

  • Research Scope

  • Market Segmentation

  • Research Methodology

  • Definitions and Assumptions

• Executive Summary

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

• Key Insights

  • Prevalence of Diabetic Foot Ulcer by Key Countries/Regions

  • The Regulatory Scenario by Key Countries/Regions

  • Overview of New Product Launches and Developments

  • Key Industry Developments (Mergers, Acquisitions, and Partnerships)

• Global Diabetic Foot Ulcer (DFU) Treatment Market Analysis, Insights and Forecast, 2016-2027

• • Key Findings / Summary

• • Market Analysis, Insights and Forecast – By Ulcer Type

    • Neuropathic Ulcer

    • Ischemic Ulcer

    • Neuro-Ischemic Ulcer

  • Market Analysis, Insights and Forecast – By Product

    • Wound-care Dressings

• • • • Antimicrobial Dressing

      • Foam Dressing

      • Film Dressings

      • Alginate Dressings

      • Hydrogel Dressings

      • Other Dressings

• • • Wound-care Devices -

• • • • Negative Pressure Wound Therapy

      • Ultrasound Therapy

      • HBOT

      • Others

• • • Active Therapies

• • • • Skin Grafts & Substitutes,

      • Growth Factors

      • Others

• • • Others

  • Market Analysis, Insights and Forecast – By End User

    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

    • Homecare Settings

  • Market Analysis, Insights and Forecast – By Region

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

ToC Continue…!

Frequently Asked Questions

How much will the global market be worth in 2027?

                According to Fortune Business Insights, the global market will reach USD 11.05 billion by 2027.

What are the key factors driving the market?

                The rising prevalence of diabetic foot ulcer among the global population and the introduction of technologically advanced treatment options by market players are the key factors driving the market.

About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Address:
Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com